GleamWall
中文EN

ENOV Enovis CORP

Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE · SEC CIK 1420800 · Fiscal year ends 12/31

Financial factors as of 2026-10-02 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY3.3%
TTM net income YoY61.4%
TTM EPS YoY62.1%
Revenue 3-yr CAGR11.6%
Net income 3-yr CAGR—

Margins

Gross margin61.3%
Operating margin-20.6%
Net margin-22.9%
FCF margin3.0%
EBITDA margin37.7%

Returns

ROE-30.0%
ROA-12.9%
ROIC (approx.)-12.3%
Asset turnover0.56x

Leverage & solvency

Liabilities / assets60.0%
Debt / equity0.84x
Current ratio2.15x
Interest coverage-14.69x

Cash quality & payout

Operating cash flow / net income-0.49x
Accruals ratio-19.3%
Payout ratio—
Capex / revenue8.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-10-022026Q22026-07-032026Q12026-04-032025Q4*2025-12-312025Q32025-10-032025Q22025-07-042025Q12025-04-042024Q4*2024-12-31
Income statement
Revenue$558.73M$582.78M$589.15M$575.76M$548.91M$564.54M$558.83M$560.98M
Cost of revenue$218.88M$223.53M$223.67M$226.34M$220.00M$229.85M$226.60M$253.46M
Gross profit$339.85M$359.25M$365.49M$349.42M$328.91M$334.70M$332.23M$307.52M
R&D expense$31.27M$31.69M$31.53M$31.36M$29.74M$30.70M$28.53M$23.95M
SG&A expense$259.38M$263.73M$282.81M$270.44M$263.62M$267.07M$269.02M$257.71M
Operating income$3.38M$17.41M$6.53M-$502.18M-$558.49M-$16.80M-$46.77M-$664.75M
Interest expense$7.62M$8.04M$9.17M$7.51M$8.83M$9.29M$9.19M$9.07M
Pretax income-$456,000$7.46M$634,000-$509.55M-$566.87M-$25.65M-$57.35M-$673.73M
Income tax-$1.68M$8.50M$9.04M$9.26M$4.00M$10.80M-$1.77M$29.90M
Net income$3.14M-$1.19M-$8.76M-$520.59M-$571.15M-$36.74M-$55.97M-$703.34M
EBITDA$76.88M$88.44M$79.89M$624.58M-$484.11M$54.76M$24.67M$52.69M
EPS (basic)0.06-0.02-0.15—-9.99-0.64-0.98—
EPS (diluted)0.06-0.02-0.15—-9.99-0.64-0.98—
Weighted avg. shares (diluted)58.49M57.60M57.31M—57.17M57.13M56.79M—
Banking
Net interest income-$7.62M-$8.04M-$9.17M—-$8.83M-$9.29M-$9.19M—
Balance sheet
Cash & equivalents$13.04M$12.56M$33.13M$36.39M$33.62M$44.07M$38.46M$48.17M
Receivables$428.29M$441.85M$444.21M$442.79M$431.77M$453.70M$435.62M$407.03M
Inventory$620.15M$601.66M$602.54M$584.38M$613.75M$628.22M$585.91M$547.12M
Current assets$1.25B$1.21B$1.24B$1.21B$1.28B$1.28B$1.22B$1.15B
PP&E, net$526.32M$527.53M$519.72M$507.06M$486.42M$460.13M$426.29M$404.50M
Goodwill$702.09M$709.85M$711.90M$718.30M$1.22B$1.78B$1.73B$1.69B
Intangibles$1.09B$1.15B$1.19B$1.24B$1.28B$1.34B$1.34B$1.32B
Total assets$3.74B$3.77B$3.83B$3.83B$4.43B$5.02B$4.88B$4.72B
Current liabilities$579.84M$612.05M$608.66M$598.47M$575.44M$568.18M$477.42M$529.00M
Short-term debt$35.00M$37.39M$35.00M$35.00M$20.00M$20.03M$20.03M$20.03M
Long-term debt$1.22B$1.25B$1.29B$1.26B$1.34B$1.37B$1.37B$1.31B
Total debt$1.26B$1.28B$1.33B$1.30B$1.36B$1.39B$1.39B$1.33B
Total liabilities$2.24B$2.29B$2.35B$2.34B$2.41B$2.44B$2.25B$2.15B
Shareholders' equity$1.49B$1.48B$1.48B$1.49B$2.02B$2.58B$2.62B$2.56B
Net debt$1.25B$1.27B$1.29B$1.26B$1.33B$1.35B$1.35B$1.28B
Shares outstanding57.69M57.67M57.55M57.19M57.19M57.16M57.12M55.88M
Cash flow statement
Operating cash flow$71.49M$75.03M$23.95M$88.54M$82.58M$47.77M-$1.60M$88.33M
Capital expenditure$36.51M$43.90M$52.80M$56.25M$53.49M$44.37M$43.26M$53.19M
Free cash flow$34.99M$31.14M-$28.85M$32.29M$29.09M$3.40M-$44.86M$35.14M
Investing cash flow-$42.50M-$45.01M-$53.09M-$12.99M-$56.06M-$49.80M-$60.52M-$57.88M
Financing cash flow-$28.50M-$50.56M$26.02M-$72.92M-$36.91M$6.23M$51.19M-$20.08M
Depreciation & amortization$73.50M$71.03M$73.36M$1.13B$74.38M$71.55M$71.44M$717.44M
Stock-based compensation$7.54M$8.90M$8.75M$8.11M$8.96M$8.67M$7.41M$7.73M

Free plan shows the latest 8 periods; Pro shows all 68 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.